The Neuroendocrine Component in Bladder Tumors

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|21|9|1117-1128

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.21, Iss.9, 2014-03, pp. : 1117-1128

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neuroendocrine Tumors

By  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 7, Iss. 7, 2009-07 ,pp. : 712-712

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Everolimus for the treatment of pancreatic neuroendocrine tumors

By Feldmann Georg   Bisht Savita   Schütte Ute   Haarmann Jens   Brossart Peter  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 14, 2012-10 ,pp. : 2073-2084

Informa Healthcare

Access to resources Recommend Favorite

Neuroendocrine Tumors Clinical Practice Guidelines

By  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 4, Iss. 2, 2006-02 ,pp. : 102-102

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Emerging therapeutic options for advanced enteropancreatic neuroendocrine tumors

By Dasanu Constantin A   Majumder Shounak   Gopal Srila   Stoica-Mustafa Elena   Trikudanathan Guru  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 4, 2012-03 ,pp. : 461-471

Informa Healthcare

Access to resources Recommend Favorite

Emerging therapies for the treatment of patients with advanced neuroendocrine tumors

By Chan Jennifer A   Kulke Matthew H  

Expert Opinion on Emerging Drugs, Vol. 12, Iss. 2, 2007-05 ,pp. : 253-270

Informa Healthcare

Access to resources Recommend Favorite